Cardo mariano

Silybum marianum (L.) Gaertn


  • Alarc¢n de la Lastra A, Mart¡n M, Motilva V, et al.(1995) Gastroprotection induced by silymarin, the hepatoprotective principle of Silybum marianum in ischemia-reperfusion mucosalinjury: role of neutrophils. Planta Med. ;61:116-119.
  • Feher J, Deak G, Muzes G, Lang I, Neiderland V, Nekan K, et al. (1990) Hepatoprotective activity of silymarin therapy in patients with chronic alcoholic liver disease. Orv Hetil. ;130:51.
  • Ferenci P, Dragosics B, Dittrich H, Frank H., Benda L, Lochs H, et al. (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. ;9:105-13.
  • Flora K, Hahn M, Rosen H, Benner K.(1998) Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. ;93:139-43.
  • Magliulo E, Gagliardi B, Fiori GP (1978) . Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres. Med Klinik. ;73:
  • Mills SY, and Bone K (1999) Principle and Practice of Phytotoerapy. Churchill and Livingstone, London pp. 553-561
  • Morazzoni P, Bombardelli E. (1995) Silybum marianum (Carduus marianus). Fitoterapia. ;LXVI.
  • Palasciano G, Portincasa P, Palmieri V, Ciani D, Vendemiale G, Altomare E. (1994) The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs. Curr Therapeut Res. ;55(5):537-545.
  • Stevens, P.F. (2001 onwards). Angiosperm Phylogeny Website. Version 5, May 2004 [and more or less continuously updated since].